Study Finds Strong Connection Between Hysterectomy and Higher Stroke Risk

A recent scientific investigation has identified a significant association between undergoing a hysterectomy and an increased risk of stroke, raising important questions about the long-term health implications for women who have had this common surgical procedure.

New Data Fuels Concern Over Hysterectomy and Stroke Risk

Mounting evidence is prompting a reconsideration of one of the most frequent surgeries performed on women in the United States: the hysterectomy. This procedure, sometimes combined with a bilateral removal of the ovaries—technically known as an ovariectomy—has historically been recommended for conditions ranging from cancer to benign fibroids or endometriosis. Yet, a growing chorus of specialists now advises that such interventions should only come as a last resort when faced with severe pathology.

Research Uncovers Elevated Stroke Risk

Over the past decade, signals have grown louder regarding a potential connection between hysterectomy—with or without ovary removal—and an increased likelihood of stroke. The latest meta-analysis, encompassing more than two million patients, adds weight to this concern. The data reveals a 5% uptick in stroke risk following hysterectomy (including uterine and cervical removal), while removal of both ovaries elevates this risk sharply to 18%.

What could explain this? Many researchers believe the sudden loss of ovarian hormones may trigger premature menopause, which itself has well-documented negative impacts on cardiovascular health. Although the exact biological mechanisms remain unclear, the hormonal deficit appears central to these findings.

Evolving Medical Perspectives

It’s worth recalling that before 2000, American surgical practice often included routine ovary removal during hysterectomies. However, subsequent studies shifted that approach. A pivotal 2009 analysis already highlighted a broader rise in mortality among women who underwent early ovary removal—even when treating non-cancerous conditions. More nuanced research followed: in 2018, for instance, some suggested that estrogen replacement therapy might help mitigate elevated risks in younger women.

Nevertheless, comprehensive reviews persistently reinforce caution. A recent synthesis—drawing on American national data from 1999 to 2018 and fifteen other international studies—urges ongoing vigilance and tailored patient care.

Recommendations for Safer Care Pathways

Given these concerns, experts now stress several key steps before and after performing such surgeries:

• Thoroughly assess each patient’s cardiovascular profile
• Pursue non-surgical alternatives where feasible
• Ensure close medical follow-up post-procedure

As Dr. Stephanie Faubion, medical director at The Menopause Society, puts it: “These findings highlight that common procedures can have significant long-term risks.” It is a reminder for clinicians—and their patients—to weigh every option carefully when facing gynecological disease management.